The Genetic Factors Influencing Cardiomyopathies and Heart Failure across the Allele Frequency Spectrum

J Cardiovasc Transl Res. 2024 Oct;17(5):1119-1139. doi: 10.1007/s12265-024-10520-y. Epub 2024 May 21.

Abstract

Heart failure (HF) remains a major cause of mortality and morbidity worldwide. Understanding the genetic basis of HF allows for the development of disease-modifying therapies, more appropriate risk stratification, and personalised management of patients. The advent of next-generation sequencing has enabled genome-wide association studies; moving beyond rare variants identified in a Mendelian fashion and detecting common DNA variants associated with disease. We summarise the latest GWAS and rare variant data on mixed and refined HF aetiologies, and cardiomyopathies. We describe the recent understanding of the functional impact of titin variants and highlight FHOD3 as a novel cardiomyopathy-associated gene. We describe future directions of research in this field and how genetic data can be leveraged to improve the care of patients with HF.

Keywords: Cardiomyopathy; Genetics; Heart failure.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiomyopathies* / genetics
  • Connectin* / genetics
  • Gene Frequency*
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study*
  • Heart Failure* / diagnosis
  • Heart Failure* / genetics
  • Heart Failure* / physiopathology
  • Heart Failure* / therapy
  • Humans
  • Phenotype*
  • Prognosis
  • Risk Factors

Substances

  • Connectin
  • TTN protein, human